ARCHIVES

Phase III Trial: Panobinostat Increases PFS by Four Months

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Gori Tells McGovern Committee Diet Causes Major Share Of Cancer

August 6, 1976

FDA developing guidelines for oncology endpoints.

May 7, 2004

Phase IIb Trial of CRLX101 Fails Overall Survival Endpoint

March 29, 2013

Epstein Hits NCI On Doll, Peto Reports, Greenwald Responds

July 3, 1992

Sexual Function Affected By Stem Cell Transplant

September 28, 2007

Cancer Rates May Rise 50% By 2020, IARC Says

April 18, 2003